The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Pelvic Inflammatory Disease (PID) Treatment Market Progress Between 2026 And 2030?
The pelvic inflammatory disease (PID) treatment market has experienced robust expansion over recent years. Projections indicate its value will increase from $4.74 billion in 2025 to $5 billion by 2026, advancing at a compound annual growth rate (CAGR) of 5.5%. Historically, this expansion has been primarily driven by factors such as the widespread occurrence of sexually transmitted infections, inadequate understanding of PID, the common use of broad-spectrum antibiotics, challenges in early diagnosis stemming from asymptomatic instances, and restricted availability of expert gynecological services.
The market for pelvic inflammatory disease (PID) treatment is projected to experience substantial growth over the coming years. By 2030, this market is anticipated to reach $6.13 billion, expanding at a compound annual growth rate (CAGR) of 5.3%. Key factors driving this expansion during the forecast period include the increasing adoption of combination antibiotic therapy, a rise in the use of hormonal therapy for prevention, progress in minimally invasive surgical techniques, the expansion of telehealth and remote monitoring solutions, and enhanced awareness and education initiatives aimed at early detection. Significant trends expected in the same period involve the increasing application of AI for early diagnosis and risk stratification, a growing move towards genomics-based personalized treatment methods, the integration of cloud and big data for patient monitoring and management, the utilization of IoT-enabled devices for tracking symptoms remotely, and the adoption of smart manufacturing processes in the production of antibiotics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21251&type=smp
Which Primary Drivers Are Impacting The Pelvic Inflammatory Disease (PID) Treatment Market Growth?
The rising occurrence of sexually transmitted infections is anticipated to boost the expansion of the pelvic inflammatory disease (PID) treatment market in the coming years. STIs are infections primarily transmitted through sexual activity—such as vaginal, anal, or oral sex—caused by bacteria, viruses, or parasites. The growing number of STIs can be attributed to elements like unsafe sexual practices, unprotected intercourse, insufficient public knowledge, and delays in diagnosis and care. Managing sexually transmitted infections benefits from pelvic inflammatory disease (PID) treatment because it employs antibiotics to eradicate the bacteria causing infection, averts complications like persistent pelvic pain and infertility, and lowers the likelihood of repeated infections. For instance, in October 2024, according to a report published by the UK Health Security Agency (UKHSA), a UK-based government agency, in 2023, England recorded 6,008 new human immunodeficiency virus (HIV) diagnoses, marking a 51% increase compared to the 3,975 diagnoses in 2022. Consequently, the increasing prevalence of sexually transmitted infections is propelling the growth of the pelvic inflammatory disease (PID) treatment market. The growing integration of telemedicine is anticipated to fuel the expansion of the telehealth solutions market moving ahead. Telemedicine involves providing medical services remotely via digital channels, such as video appointments, health applications for mobile devices, and remote patient oversight. The increasing embrace of telemedicine stems from factors like the demand for easy access to care, a scarcity of medical professionals in some areas, progress in digital infrastructure, and patients’ preference for virtual appointments. Telehealth solutions prove beneficial for overseeing patient care by facilitating remote diagnostics and observation, enhancing availability of healthcare services, cutting down on travel and wait times, and supporting prompt actions for long-term and sudden health issues. For instance, in March 2023, according to the Office of the National Coordinator for Health Information Technology (ONC), a US based government agency, reported that more than 80% of physicians used telemedicine for less than 50% percent of their patients. As a result, the increasing adoption of telemedicine is driving the growth of the pelvic inflammatory disease (PID) treatment market.
What Are The Main Segments Within The Pelvic Inflammatory Disease (PID) Treatment Market Segment Structure?
The pelvic inflammatory disease (pid) treatment market covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy, Surgery, Pain Management
2) By Route Of Administration: Oral, Intravenous, Intramuscular
3) By End User: Hospitals, Clinics, Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics, Combination Antibiotic Therapy, Oral Antibiotics, Intravenous Antibiotics
2) By Surgery: Laparoscopy, Hysterectomy, Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen, Localized Pain Management
Which Trends Are Shaping Growth In The Pelvic Inflammatory Disease (PID) Treatment Market?
Companies operating in the pelvic inflammatory disease (PID) treatment market are increasingly focusing on developing innovative formulations, particularly probiotic supplements, to improve treatment efficacy, re-establish vaginal microbiota balance, and lower the rate of recurrent infections in patients with pelvic inflammatory disease (PID). A probiotic supplement is defined as a product containing beneficial live bacteria or yeasts that aid in maintaining or restoring a healthy equilibrium of gut and vaginal microbiota. As an illustration, in November 2024, Lee Health Domain, an India-based pharmaceutical company, introduced V-Ferin, a probiotic supplement formulated to support vaginal health. This product, containing Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, is intended to restore the natural microbiome and prevent common vaginal infections such as bacterial vaginosis and yeast infections. With approximately 25-30% of women affected by these conditions, which can lead to pelvic inflammatory disease if not addressed, V-Ferin offers a new solution to enhance health and prevent complications.
Who Are The Companies Participating In The Pelvic Inflammatory Disease (PID) Treatment Market?
Major companies operating in the pelvic inflammatory disease (pid) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences
Get The Full Pelvic Inflammatory Disease (PID) Treatment Market Report:
Which Geographic Region Dominates The Pelvic Inflammatory Disease (PID) Treatment Market?
North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (pid) treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pelvic Inflammatory Disease (PID) Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Pelvic Inflammatory Disease (PID) Treatment Market 2026, By The Business Research Company
Urinary Tract Cancer Market Report 2026
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
Interstitial Cystitis Drugs Market Report
https://www.thebusinessresearchcompany.com/report/interstitial-cystitis-drugs-global-market-report
Ovarian Cancer Diagnostics Market Report
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model